Target Name: CAPS2
NCBI ID: G84698
Other Name(s): FLJ34520 | Calcyphosine 2, transcript variant 1 | Calcyphosin-2 (isoform 1) | calcyphosine 2 | CAPS2 variant 1 | Calcyphosin-2 (isoform 3) | Calcyphosphine 2 | Calcyphosine 2, transcript variant 3 | Calcyphosin-2 | CAYP2_HUMAN | OTTHUMP00000202412 | UG0636c06 | Calcyphosine-2 | CAPS2 variant 3 | calcyphosphine 2

Unlocking The Functions of CAPS2: Potential Drug Targets and Biomarkers

CAPS2 (Complement Component A, Sub-Type II) is a protein that is expressed in many different tissues throughout the body, including the heart, lungs, kidneys, and intestines. It is a key component of the complement system, which is a group of proteins that work together to help the body fight off infections.

One of the functions of CAPS2 is to help regulate the activity of the complement system. This is important because when the complement system is activated, it can cause a host of different biological responses throughout the body, including the production of antibodies and the formation of clots.

CAPS2 is also involved in the regulation of inflammation. When the body is exposed to an infection or injury, CAPS2 helps to coordinate the immune response by regulating the production of antibodies and the release of other immune cells.

Despite its many important functions, CAPS2 is not well understood. In fact, there is currently no cure for CAPS2-related diseases, and researchers are still trying to determine just how this protein plays a role in the body.

One potential drug target for CAPS2 is the use of small molecules, such as drugs that can modulate the activity of CAPS2. This approach is being explored as a potential treatment for a range of diseases, including heart failure, lung disease, and kidney failure.

Another potential application for CAPS2 is its use as a biomarker. By analyzing the expression of CAPS2 in different tissues and cells, researchers can gain insights into the underlying biology of a disease. This can help to identify new targets for treatment and diagnosis, as well as to monitor the effectiveness of existing treatments.

Overall, CAPS2 is a protein that is still being studied, and there is a lot we still do not know about its functions and applications. Further research is needed to fully understand the role of CAPS2 in the body, and to explore its potential as a drug target and biomarker.

Protein Name: Calcyphosine 2

More Common Targets

CAPSL | CAPZA1 | CAPZA2 | CAPZA3 | CAPZB | Carbonic Anhydrase | Carbonic Anhydrase V | Carboxylesterase | Carboxypeptidase A | Carboxypeptidase B | Carboxypeptidase N | Carcinoembryonic Antigen-Related Cell Adhesion Molecule (CEA) | CARD10 | CARD11 | CARD14 | CARD16 | CARD17P | CARD18 | CARD19 | CARD6 | CARD8 | CARD8-AS1 | CARD9 | Cardiac Troponin | CARF | CARHSP1 | CARM1 | CARMAL | CARMIL1 | CARMIL2 | CARMIL3 | CARMN | Carnitine O-Palmitoyltransferase (CPT) | Carnitine O-Palmitoyltransferase 1 (CPT-1) | Carnitine O-palmitoyltransferase 2 | CARNMT1 | CARNS1 | CARS1 | CARS1-AS1 | CARS2 | CARTPT | CASC11 | CASC15 | CASC16 | CASC17 | CASC18 | CASC19 | CASC2 | CASC20 | CASC21 | CASC22 | CASC3 | CASC6 | CASC8 | CASC9 | CASD1 | Casein Kinase | Casein kinase I | Casein Kinase I gamma | Casein kinase II (CKII) | CASK | CASKIN1 | CASKIN2 | CASKP1 | CASP1 | CASP10 | CASP12 | CASP14 | CASP16P | CASP1P2 | CASP2 | CASP3 | CASP4 | CASP4LP | CASP5 | CASP6 | CASP7 | CASP8 | CASP8AP2 | CASP9 | Caspase | CASQ1 | CASQ2 | CASR | CASS4 | CAST | CASTOR1 | CASTOR2 | CASTOR3P | CASZ1 | CAT | Cathepsin | CATIP | CATIP-AS1 | CATSPER1 | CATSPER2 | CATSPER2P1 | CATSPER3 | CATSPER4 | CATSPERB